In-vitro process for quick determination of the status of an infection with an influenza virus type
The novel test system can discriminate T cell immunity induced by an acute encounter of influenza viruses from lasting T cell immunity after earlier infections or preceding vaccinations. The test system can be performed out of whole blood, following a multi-dimensional T cell immunomonitoring of cytokine profiles after specific antigen stimulation with a processing time of 8 hours.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Combining robotics and ChatGPT
TUM professor uses ChatGPT for choreographies with flying robots. Prof. Angela Schoellig has proved that large language models can be used safely in robotics. ChatGPT develops choreographies for up to…
How the Immune System Learns from Harmless Particles
Our lungs are bombarded by all manner of different particles every single day. Whilst some are perfectly safe for us, others—known as pathogens—have the potential to make us ill. The…
Biomarkers identified for successful treatment of bone marrow tumours
CAR T cell therapy has proven effective in treating various haematological cancers. However, not all patients respond equally well to treatment. In a recent clinical study, researchers from the University…